Hemrajani Rekha

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hemrajani Rekha's trades of MaxCyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US MaxCyte Inc (MXCT)
Transaction date
Planned sale
Price
113.57
Quantity 31,293 +49.7%
Value US$4,636,079
US MaxCyte Inc (MXCT)
Transaction date
Proposed sale
Price
337.80
Quantity 55,725
Value US$532,901
Transaction date
Purchase
Price
19.00
Quantity 3,000 +inf%
Value US$57,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-27 2025-06-25
US MaxCyte Inc (MXCT)
PlS Planned sale
31,293 +49.7%
113.57
US$4,636,079 		31,293 +49.7% 113.57 US$4,636,079
2025-06-25 2025-06-25
US MaxCyte Inc (MXCT)
PrS Proposed sale
55,725
337.80
US$532,901 		55,725 337.80 US$532,901
2024-12-04 2024-12-02
B Purchase
70,914 -35.5%
461.07
US$1,300,315 		70,914 -35.5% 461.07 US$1,300,315
2020-07-21 2020-07-21
B Purchase
3,000 +inf%
19.00
US$57,000 		3,000 +inf% 19.00 US$57,000